PATHOLOGICAL OUTCOME OF HER2/NEU-POSITIVE EARLY BREAST CANCER PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY. (2025). Frontier in Medical and Health Research, 3(7), 1552-1558. https://fmhr.net/index.php/fmhr/article/view/1887